Remote monitoring vs standard care for IBD treatment changes
Part of Digestive system clinical trials.
This study compares using a mobile app (GutyCare) to track your IBD symptoms remotely versus usual care, for people starting or changing a biologic or small molecule treatment. It aims to see if remote monitoring helps manage your condition better during this important treatment change.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease or ulcerative colitis diagnosed at least 3 months ago.
- You are starting a new biologic or small molecule treatment, or changing your current one.
- You have active symptoms from your IBD right now.
- You have not had major abdominal surgery (like a stoma or large bowel resection), and you don't have a current abscess or active perianal disease.
- You are willing and able to use a mobile app called GutyCare for remote check-ins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with Crohn's disease, ulcerative colitis, or unclassified IBD to better understand the links between these conditions, cancer, and serious infections. It asks you to share personal details and complete online surveys over time.
This study tests whether a smartphone app called SMART IBD can help children with IBD take their medications more consistently. It is for children who are currently missing more than 1 in 7 doses of their daily or weekly IBD medication.
This trial tests whether remote monitoring, using an app and home stool tests, can be a safe alternative to frequent clinic visits for people with stable IBD. If you qualify, you'll have fewer in-person appointments and more flexibility.
This trial tests if regular video check-ins via phone or computer can help people with IBD stick to their medications and feel better emotionally. You would use a messaging app and video calls to stay in touch with your care team from home.
This study tests whether digital tools, like a smartphone app and a wearable activity tracker, can help monitor your inflammatory bowel disease (IBD). You would use these tools and answer questionnaires to help doctors better understand your condition.
This trial tests an app that lets you check in with your IBD care team only when you need to, instead of having regular appointments. It's for people with Crohn's disease or ulcerative colitis who are doing well and have been on the same medication for at least 3 months.
Hear when a new IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.